Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review
Czech and Slovak Ophthalmology · 2026
DOI: 10.31348/2026/28 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Czech and Slovak Ophthalmology, 2026. Verfasst von Petra Kéri und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glaucoma Drainage Implants, Glaucoma, Open-Angle.
Abstract (Originalsprache)
Preserflo MicroShunt (Santen Pharmaceutical, Osaka, Japan) is a new drainage implant designed for controlling intraocular pressure (IOP) in patients with open-angle glaucoma in cases where conservative therapy has failed. The implant, made of biocompatible SIBS material, drains aqueous humor from the anterior chamber to the sub-Tenon’s space, ensuring the long-term reduction of IOP. This review article summarizes the available clinical and experimental data on the Preserflo MicroShunt, compares its efficacy and safety to traditional trabeculectomy, and defines its role within the current glaucoma surgery algorithm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Kéri, P., Herdová, L., Takáčová, A., & Majtánová, N. (2026). Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2026/28
Vancouver
Kéri P, Herdová L, Takáčová A, Majtánová N. Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review. Czech and Slovak Ophthalmology. 2026. doi:10.31348/2026/28
BibTeX
@article{Kri2026,
author = {Kéri, Petra and Herdová, Lucia and Takáčová, Adriana and Majtánová, Nora},
title = {Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review},
journal = {Czech and Slovak Ophthalmology},
year = {2026},
doi = {10.31348/2026/28}
}
EUVIMED